• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.比较特发性扩张型或缺血性心肌病患者和因一级预防植入除颤器患者的室性心动过速特征。
Clin Cardiol. 2011 Oct;34(10):604-9. doi: 10.1002/clc.20949. Epub 2011 Sep 1.
2
Dyssynchrony and the risk of ventricular arrhythmias.不同步与室性心律失常风险。
JACC Cardiovasc Imaging. 2013 Apr;6(4):432-44. doi: 10.1016/j.jcmg.2012.12.008.
3
Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.多中心心脏再同步治疗自动除颤器植入试验(MADIT-CRT)中室性心律失常或死亡的器械治疗的性别差异
J Cardiovasc Electrophysiol. 2015 Aug;26(8):862-871. doi: 10.1111/jce.12701. Epub 2015 Jun 17.
4
Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%.特发性扩张型心肌病、动态心电图显示非持续性室性心动过速且左心室射血分数低于30%的患者植入式除颤器事件发生率。
J Am Coll Cardiol. 2002 Mar 6;39(5):780-7. doi: 10.1016/s0735-1097(01)01822-8.
5
Ventricular arrhythmias in patients with newly diagnosed nonischemic cardiomyopathy: Insights from the PROLONG study.新诊断的非缺血性心肌病患者的室性心律失常:来自PROLONG研究的见解。
Clin Cardiol. 2017 Aug;40(8):586-590. doi: 10.1002/clc.22706. Epub 2017 Mar 23.
6
Regional Longitudinal Deformation Improves Prediction of Ventricular Tachyarrhythmias in Patients With Heart Failure With Reduced Ejection Fraction: A MADIT-CRT Substudy (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy).区域纵向变形改善对射血分数降低的心力衰竭患者室性快速心律失常的预测:一项MADIT-CRT子研究(多中心自动除颤器植入试验-心脏再同步治疗)
Circ Cardiovasc Imaging. 2017 Jan;10(1). doi: 10.1161/CIRCIMAGING.116.005096.
7
Gender difference in arrhythmic occurrences in patients with nonischemic dilated cardiomyopathy and implantable cardioverter-defibrillator.非缺血性扩张型心肌病合并植入式心律转复除颤器患者心律失常发生情况的性别差异
Heart Vessels. 2010 Mar;25(2):150-4. doi: 10.1007/s00380-009-1181-y. Epub 2010 Mar 26.
8
Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.多非利特可降低室性心律失常和植入式心脏复律除颤器治疗的频率。
J Cardiovasc Electrophysiol. 2012 Mar;23(3):296-301. doi: 10.1111/j.1540-8167.2011.02183.x. Epub 2011 Sep 28.
9
Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.在患有特发性扩张型心肌病且植入式心脏复律除颤器用于二级预防的患者中,诱发心室颤动而非室性心动过速可预测快速性心律失常复发。
Europace. 2009 Mar;11(3):289-96. doi: 10.1093/europace/eun330. Epub 2008 Dec 18.
10
Prophylactic catheter ablation for induced monomorphic ventricular tachycardia in patients with implantable cardioverter defibrillators as primary prevention.作为一级预防,对植入式心脏复律除颤器患者进行诱发单形性室性心动过速的预防性导管消融。
Europace. 2013 Oct;15(10):1507-15. doi: 10.1093/europace/eut050. Epub 2013 Apr 19.

引用本文的文献

1
Contemporary Management and Prognostic Factors of Arrhythmia Recurrence in Patients with High-Energy Discharge of Cardiac Implantable Electronic Devices.心脏植入式电子设备高能量放电患者心律失常复发的当代管理和预后因素。
Medicina (Kaunas). 2024 Oct 10;60(10):1662. doi: 10.3390/medicina60101662.
2
Management of patients with an electrical storm or clustered ventricular arrhythmias: a clinical consensus statement of the European Heart Rhythm Association of the ESC-endorsed by the Asia-Pacific Heart Rhythm Society, Heart Rhythm Society, and Latin-American Heart Rhythm Society.管理电风暴或簇发性室性心律失常患者:欧洲心脏病学会心律协会的临床共识声明——由亚太心律学会、心律学会和拉丁美洲心律学会认可。
Europace. 2024 Mar 30;26(4). doi: 10.1093/europace/euae049.
3
[Catheter ablation of ventricular tachycardia-Update 2023].[室性心动过速的导管消融——2023年更新]
Herz. 2023 Jun;48(3):247-256. doi: 10.1007/s00059-023-05167-5. Epub 2023 May 2.
4
Transvenous or subcutaneous implantable cardioverter defibrillator: a review to aid decision-making.经静脉或皮下植入式心律转复除颤器:辅助决策的综述
J Interv Card Electrophysiol. 2022 Jul 14. doi: 10.1007/s10840-022-01299-6.
5
[Subcutaneous implantable cardioverter-defibrillator : Current status and perspectives].[皮下植入式心脏复律除颤器:现状与展望]
Herzschrittmacherther Elektrophysiol. 2018 Dec;29(4):349-354. doi: 10.1007/s00399-018-0593-8. Epub 2018 Oct 10.
6
Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction.长期心脏收缩力调节(CCM)对左心室收缩功能障碍引起心力衰竭患者的临床疗效。
Clin Res Cardiol. 2017 Nov;106(11):893-904. doi: 10.1007/s00392-017-1135-9. Epub 2017 Jul 6.
7
Implantable cardioverter/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and systematic review of randomized controlled trials.植入型心律转复除颤器在扩张型心肌病中的一级预防:DANISH 试验后的更新荟萃分析和随机对照试验的系统评价。
Clin Res Cardiol. 2017 Jul;106(7):501-513. doi: 10.1007/s00392-017-1079-0. Epub 2017 Feb 17.
8
Use of Implantable Cardioverter Defibrillators in Heart Failure Patients and Risk of Mortality: A Meta-Analysis.植入式心脏复律除颤器在心力衰竭患者中的应用与死亡风险:一项荟萃分析。
Med Sci Monit. 2015 Jun 21;21:1792-7. doi: 10.12659/MSM.893681.
9
Follow-up of implantable cardioverter-defibrillator therapy: comparison of coronary artery disease and dilated cardiomyopathy.植入式心脏复律除颤器治疗的随访:冠状动脉疾病与扩张型心肌病的比较。
Neth Heart J. 2014 Oct;22(10):431-7. doi: 10.1007/s12471-014-0595-z.
10
[Current status and problems of the entirely subcutaneous ICD (S-ICD®)].[完全皮下植入式心律转复除颤器(S-ICD®)的现状与问题]
Herzschrittmacherther Elektrophysiol. 2013 Sep;24(3):165-70. doi: 10.1007/s00399-013-0277-3.

本文引用的文献

1
Prophylactic implantation of cardioverter defibrillators in idiopathic nonischemic cardiomyopathy for the primary prevention of death: a narrative review.特发性非缺血性心肌病患者一级预防死亡的预防性植入心脏转复除颤器:叙事性综述。
Clin Cardiol. 2010 May;33(5):254-60. doi: 10.1002/clc.20757.
2
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.植入式心脏复律除颤器、胺碘酮和安慰剂对心力衰竭稳定患者死亡方式的影响:心力衰竭猝死试验的分析。
Circulation. 2009 Dec 1;120(22):2170-6. doi: 10.1161/CIRCULATIONAHA.109.853689. Epub 2009 Nov 16.
3
A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.对植入式心脏复律除颤器预防心源性猝死治疗的批判性评价。
J Am Coll Cardiol. 2008 Sep 30;52(14):1111-21. doi: 10.1016/j.jacc.2008.05.058.
4
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).《2008年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南》:欧洲心脏病学会2008年急性和慢性心力衰竭诊断与治疗特别工作组制定。与欧洲心脏病学会心力衰竭协会(HFA)合作编写,并得到欧洲重症医学学会(ESICM)认可。
Eur Heart J. 2008 Oct;29(19):2388-442. doi: 10.1093/eurheartj/ehn309. Epub 2008 Sep 17.
5
Mechanistic insights into ventricular arrhythmias from mapping studies in humans.来自人体标测研究的室性心律失常机制洞察
Heart Rhythm. 2008 Jun;5(6 Suppl):S53-8. doi: 10.1016/j.hrthm.2008.03.028. Epub 2008 Mar 27.
6
Incidence and characteristics of appropriate and inappropriate therapies in recipients of ICD implanted for primary prevention of sudden cardiac death.
Pacing Clin Electrophysiol. 2007 Jan;30 Suppl 1:S125-7. doi: 10.1111/j.1540-8159.2007.00621.x.
7
Implantable cardioverter defibrillators for prevention of sudden cardiac death.用于预防心源性猝死的植入式心脏复律除颤器
Clin Cardiol. 2007 Jan;30(1):3-8. doi: 10.1002/clc.20001.
8
Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial.植入式心脏除颤器患者的电风暴:发生率、特征及预防性治疗:一项随机试验的见解
Eur Heart J. 2006 Dec;27(24):3027-32. doi: 10.1093/eurheartj/ehl276. Epub 2006 Oct 18.
9
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.美国心脏病学会/美国心脏协会/欧洲心脏病学会2006年室性心律失常患者管理及心脏性猝死预防指南——执行摘要:美国心脏病学会/美国心脏协会特别工作组及欧洲心脏病学会实践指南委员会(制定室性心律失常患者管理及心脏性猝死预防指南写作委员会)报告。与欧洲心律协会和心律学会合作制定。
Eur Heart J. 2006 Sep;27(17):2099-140. doi: 10.1093/eurheartj/ehl199.
10
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.胺碘酮或植入式心脏复律除颤器用于治疗充血性心力衰竭。
N Engl J Med. 2005 Jan 20;352(3):225-37. doi: 10.1056/NEJMoa043399.

比较特发性扩张型或缺血性心肌病患者和因一级预防植入除颤器患者的室性心动过速特征。

Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.

机构信息

First Department of Medicine-Cardiology, University Medical Centre and Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.

出版信息

Clin Cardiol. 2011 Oct;34(10):604-9. doi: 10.1002/clc.20949. Epub 2011 Sep 1.

DOI:10.1002/clc.20949
PMID:21887690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6652319/
Abstract

BACKGROUND

Implantable cardioverter-defibrillator (ICD) therapy for primary prevention is well established in ischemic cardiomyopathy (ICM). Data on the role of ICDs in patients with dilated cardiomyopathy (DCM) and no history of ventricular tachyarrhythmia (VT/VF) are more limited.

HYPOTHESIS

DCM patients with an impaired left ventricular ejection fraction (LVEF) still represent a low arrhythmic risk subgroup in clinical practice.

METHODS

ICD stored data of DCM patients with an LVEF ≤35% was compared to data of ICM patients meeting Multicenter Automatic Defibrillator Implantation Trial (MADIT) eligibility criteria. VT/VF occurrences and electrical storm (ES) events were analyzed.

RESULTS

There were 652 patients followed for 50.9 ± 33.9 months. There were 1978 VT and 241 VF episodes analyzed in 66 out of 203 patients (32.5%) with DCM and in 118 out of 449 patients (26.3%, P = 0.209) with ICM. Freedom of appropriate ICD treatment due to VT/VF or ES events did not differ in both patient populations (log-rank, P>0.05). In patients presenting with VT/VF episodes, mean event rates were comparable in both patient populations (3.2 ± 14.1 for DCM and VT vs 3 ± 13.9 for ICM and VT [P = 0.855], 0.4 ± 1.3 for DCM and VF vs 0.4 ± 1.8 for ICM and VF [P = 0.763], and 0.2 ± 0.7 for DCM and ES vs 0.2 ± 1 for ICM and ES [P = 0.666]).

CONCLUSIONS

DCM patients with prophylactic ICDs implanted due to heart failure and patients fulfilling MADIT criteria reveal comparable patterns of VT/VF/ES events during long-term follow-up. Incidence, mean number of events, and time to first event did not differ significantly. Findings support the current guidelines for prophylactic ICD therapy in DCM patients with heart failure.

摘要

背景

植入式心脏复律除颤器(ICD)治疗在缺血性心肌病(ICM)中的一级预防已得到充分证实。在没有室性心动过速/心室颤动(VT/VF)病史的扩张型心肌病(DCM)患者中,ICD 的作用的数据则更为有限。

假设

在临床实践中,左心室射血分数(LVEF)降低的 DCM 患者仍代表一个心律失常风险较低的亚组。

方法

比较 LVEF≤35%的 DCM 患者的 ICD 储存数据与符合多中心自动除颤器植入试验(MADIT)入选标准的 ICM 患者的数据。分析 VT/VF 发作和电风暴(ES)事件。

结果

共有 652 例患者接受了 50.9±33.9 个月的随访。在 203 例患者中的 66 例(32.5%)和 449 例患者中的 118 例(26.3%,P=0.209)患有 DCM,共分析了 1978 次 VT 和 241 次 VF 发作。在这两个患者群体中,由于 VT/VF 或 ES 事件而接受适当 ICD 治疗的无事件生存率没有差异(对数秩检验,P>0.05)。在出现 VT/VF 发作的患者中,两个患者群体的平均事件发生率相当(DCM 和 VT 为 3.2±14.1,ICM 和 VT 为 3.0±13.9 [P=0.855],DCM 和 VF 为 0.4±1.3,ICM 和 VF 为 0.4±1.8 [P=0.763],DCM 和 ES 为 0.2±0.7,ICM 和 ES 为 0.2±1.0 [P=0.666])。

结论

由于心力衰竭而植入预防性 ICD 的 DCM 患者和符合 MADIT 标准的患者在长期随访中表现出相似的 VT/VF/ES 事件模式。发生率、平均事件数和首次事件时间无显著差异。这些发现支持当前心力衰竭 DCM 患者预防性 ICD 治疗的指南。